CLVS announcements Clovis Oncology, Inc. announcements and dividends declared NASDAQ
Clovis Oncology, Inc. Complete list of announcements declared & dividend announcements by Clovis Oncology, Inc. CLVS
Clovis Oncology, Inc. CLVS listed on NASDAQ and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Clovis Oncology, Inc. CLVS
Clovis Oncology stock slides 10% premarket after company files for bankruptcy
Clovis Oncology Inc. stock fell 10% in premarket trade Monday, after the biotech filed for Chapter 11 bankruptcy and said it would sell assets. The company has a commitment for up to million in debtor-in-possession financing to provide the liquidity n
Announcement as on 12 December 2022
Clovis Oncology Files For Chapter 11 Protection; Agrees To Sell FAP-2286 To Novartis
(RTTNews) - Clovis Oncology, Inc. (CLVS) Monday announced that certain of its subsidiaries have initiated Chapter 11 filing in the United States Bankruptcy Court for the District of Delaware and plan to sell assets through a court-supervised sales process.
Announcement as on 12 December 2022
Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023
Clovis Oncology Inc. shares plunged 75% Wednesday, after the Colorado-based biotech said it will not have sufficient liquidity to maintain operations beyond January of 2023. The company said recent regulatory developments relating to its ovarian cancer dr
Announcement as on 09 November 2022
Why Clovis Oncology Zoomed 30% Higher Today
What happened Cancer-focused biotech Clovis Oncology (NASDAQ: CLVS) was a stock on fire Monday. Investors pushed the company's share price up by more than 30% on the day, thanks to highly encouraging clinical trial results for a new indication of its oncol
Announcement as on 12 September 2022
Clovis Oncology to seek FDA approval for ovarian cancer drug as a maintenance therapy
Shares of Clovis Oncology Inc. soared 40.0% in premarket trading on Thursday after the company said its drug, Rubraca, improved survival when used as a maintenance treatment for women with ovarian cancer. The data comes from a double-blind, placebo-contro
Announcement as on 31 March 2022
Announcements by Clovis Oncology, Inc. first page | Next page |
CLVS Clovis Oncology, Inc. current price & indicator signals
Recent prices of CLVS Clovis Oncology, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 20 Tue Dec 2022 | 0.08 | 0.08 to 0.10 | -11.11% | 1.7 times |
| 19 Mon Dec 2022 | 0.09 | 0.08 to 0.09 | 12.5% | 1.38 times |
| 16 Fri Dec 2022 | 0.08 | 0.08 to 0.11 | -20% | 1.6 times |
| 15 Thu Dec 2022 | 0.10 | 0.09 to 0.11 | -9.09% | 1.09 times |
| 14 Wed Dec 2022 | 0.11 | 0.10 to 0.14 | -15.38% | 1.7 times |
| 13 Tue Dec 2022 | 0.13 | 0.13 to 0.20 | -35% | 1.3 times |
| 12 Mon Dec 2022 | 0.20 | 0.17 to 0.28 | 0% | 1.97 times |
| 09 Fri Dec 2022 | 0.20 | 0.20 to 0.23 | -9.09% | 0.17 times |
| 08 Thu Dec 2022 | 0.22 | 0.20 to 0.24 | 0% | 0.28 times |
| 07 Wed Dec 2022 | 0.22 | 0.22 to 0.25 | -12% | 0.19 times |
| 06 Tue Dec 2022 | 0.25 | 0.24 to 0.29 | -13.79% | 0.33 times |
| 05 Mon Dec 2022 | 0.29 | 0.29 to 0.32 | -14.71% | 0.31 times |
Videos related to: CLVS announcements Clovis Oncology, Inc. announcements and dividends declared NASDAQ
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


